Page 18 - Shankar Musunuri News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ocugen Announces Positive Top-Line Data for COVID-19 Vaccine Candidate COVAXIN™ (BBV152) in Phase 2/3 Immuno-bridging and Broadening Study: Both Co-primary Endpoints Met

Ocugen Announces Positive Top-Line Data for COVID-19 Vaccine Candidate COVAXIN™ (BBV152) in Phase 2/3 Immuno-bridging and Broadening Study: Both Co-primary Endpoints Met
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesAndhra pradeshShankar musunuriStates clinicaltrialsEric feiglHead of communicationsHealth economist for microclinic internationalBharat biotech internationalNational institute of virologyWorld health organizationEngland complex systems instituteIndian council of medical researchOcugen incExchange commissionFounder of the world health networkBharat biotech international limited

Nasal Vaccines Are Here

Nasal Vaccines Are Here
theatlantic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theatlantic.com Daily Mail and Mail on Sunday newspapers.

United statesWhite houseDistrict of columbiaBen cowlingStephanie langelDeepta bhattacharyaAnthony fauciAkiko iwasakiRupali limayeAli ellebedyDavid martinezShankar musunuriAdam ritchieJohns hopkins universityNational institute of allergyUniversity of hong kong

Ocugen, Inc to Ring the Nasdaq Stock Market Closing Bell

MALVERN, Pa., Dec. 13, 2022 Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Dr.. | December 13, 2022

New yorkUnited statesShankar musunuriHead of communicationsExchange commissionManagement teamOcugen incChief executive officerExecutive management teamNasdaq closing bellClosing bellNasdaq marketsite towerBiologics license applicationPrivate securities litigation reform actNc stock exchangePress release

Ocugen Provides Business Update & Third Quarter 2022 Financial Results

Ocugen Provides Business Update & Third Quarter 2022 Financial Results
mychesco.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mychesco.com Daily Mail and Mail on Sunday newspapers.

United statesShankar musunuriWashington universityDrug administrationOcugen incChief executive officerSafety monitoring boardInvestigational new drug

Ocugen, Inc (OCGN) Q3 2022 Earnings Call Transcript

OCGN earnings call for the period ending September 30, 2022.

United statesJennifer kim cantor fitzgeraldJess crespoDaniil gataulinJennifer kimJessica crespoDaniil gataulin chardanRobert leboyerShankar musunuriJonathan aschoffWorld health organizationOcugen incAmerican academy of ophthalmology conferenceExchange commissionWashington universityCantor fitzgerald